RMD Stock Up 8.5% after 7-Day Win Streak
ResMed (RMD) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 8.5% return. The company has gained about $3.4 Bil in value over the last 7 days, with its current market capitalization at about $40 Bil. The stock remains 20.1% above its value at the end of 2024. This compares with year-to-date returns of 8.2% for the S&P 500.
Comparing RMD Stock Returns With The S&P 500
The following table summarizes the return for RMD stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | RMD | S&P 500 |
|---|---|---|
| 1D | 0.0% | 0.1% |
| 7D (Current Streak) | 8.5% | 1.9% |
| 1M (21D) | 6.9% | 4.5% |
| 3M (63D) | 27.8% | 18.4% |
| YTD 2025 | 20.1% | 8.2% |
| 2024 | 34.2% | 23.3% |
| 2023 | -16.5% | 24.2% |
| 2022 | -19.5% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 102 S&P constituents with 3 days or more of consecutive gains and 14 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 72 | 7 |
| 4D | 13 | 4 |
| 5D | 5 | 3 |
| 6D | 2 | 0 |
| 7D or more | 10 | 0 |
| Total >=3 D | 102 | 14 |
- The Iran War Trade Investors Are Missing
- Broken Windows: How Microsoft Loses Its AI Premium
- GE Aerospace: Blue-Chip Performance, Red-Line Valuation
- Why Betting Against Amazon Stock In 2022 Was A Mistake
- How To Earn 12% Yield While Waiting to Buy RCL 30% Cheaper
- Where Could The Next Breakout for Applied Materials Stock Come From
Key Financials for ResMed (RMD)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $4.2 Bil | $4.7 Bil |
| Operating Income | $1.2 Bil | $1.4 Bil |
| Net Income | $897.6 Mil | $1.0 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $1.3 Bil | $1.3 Bil |
| Operating Income | $417.2 Mil | $426.3 Mil |
| Net Income | $344.6 Mil | $365.0 Mil |
While RMD stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.